Results
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
|
|
26.
|
|
|
27.
|
The tablet formulation of lopinavir/ritonavir provides similar bioavailability to the soft-gelatin capsule formulation with less pharmacokinetic variability and diminished food effect. [electronic resource] by
- Klein, Cheri Enders
- Chiu, Yi-Lin
- Awni, Walid
- Zhu, Tong
- Heuser, Renee S
- Doan, Thao
- Breitenbach, Joerg
- Morris, John B
- Brun, Scott C
- Hanna, George J
Producer: 20070710
In:
Journal of acquired immune deficiency syndromes (1999) vol. 44
Availability: No items available.
|
|
28.
|
Drug Interactions with the Direct-Acting Antiviral Combination of Ombitasvir and Paritaprevir-Ritonavir. [electronic resource] by
- Badri, Prajakta S
- Dutta, Sandeep
- Wang, Haoyu
- Podsadecki, Thomas J
- Polepally, Akshanth R
- Khatri, Amit
- Zha, Jiuhong
- Chiu, Yi-Lin
- Awni, Walid M
- Menon, Rajeev M
Producer: 20161007
In:
Antimicrobial agents and chemotherapy vol. 60
Availability: No items available.
|
|
29.
|
Effects of acid-reducing agents on the pharmacokinetics of lopinavir/ritonavir and ritonavir-boosted atazanavir. [electronic resource] by
- Klein, Cheri E
- Chiu, Yi-Lin
- Cai, Yan
- Beck, Katrin
- King, Kathryn R
- Causemaker, Sonja J
- Doan, Thao
- Esslinger, Hans-Ulrich
- Podsadecki, Thomas J
- Hanna, George J
Producer: 20080819
In:
Journal of clinical pharmacology vol. 48
Availability: No items available.
|
|
30.
|
A once-daily lopinavir/ritonavir-based regimen provides noninferior antiviral activity compared with a twice-daily regimen. [electronic resource] by
- Johnson, Margaret A
- Gathe, Joseph C
- Podzamczer, Daniel
- Molina, Jean-Michel
- Naylor, Christian T
- Chiu, Yi-Lin
- King, Martin S
- Podsadecki, Thomas J
- Hanna, George J
- Brun, Scott C
Producer: 20061128
In:
Journal of acquired immune deficiency syndromes (1999) vol. 43
Availability: No items available.
|
|
31.
|
Predictors of loss of virologic response in subjects who simplified to lopinavir/ritonavir monotherapy from lopinavir/ritonavir plus zidovudine/lamivudine. [electronic resource] by
- Campo, Rafael E
- Da Silva, Barbara A
- Cotte, Laurent
- Gathe, Joseph C
- Gazzard, Brian
- Hicks, Charles B
- Klein, Cheri E
- Chiu, Yi-Lin
- King, Martin S
- Bernstein, Barry M
Producer: 20090504
In:
AIDS research and human retroviruses vol. 25
Availability: No items available.
|
|
32.
|
Aberrant regulation favours matriptase proteolysis in neoplastic B-cells that co-express HAI-2. [electronic resource] by
- Chiu, Yi-Lin
- Wu, Yi-Ying
- Barndt, Robert B
- Yeo, Yee Hui
- Lin, Yu-Wen
- Sytwo, Hou-Ping
- Liu, Huan-Cheng
- Xu, Yuan
- Jia, Bailing
- Wang, Jehng-Kang
- Johnson, Michael D
- Lin, Chen-Yong
Producer: 20190301
In:
Journal of enzyme inhibition and medicinal chemistry vol. 34
Availability: No items available.
|
|
33.
|
Correction: Tissue distribution and subcellular localizations determine in vivo functional relationship among prostasin, matriptase, HAI-1, and HAI-2 in human skin. [electronic resource] by
- Lee, Shiao-Pieng
- Kao, Chen-Yu
- Chang, Shun-Cheng
- Chiu, Yi-Lin
- Chen, Yen-Ju
- Chen, Ming-Hsing G
- Chang, Chun-Chia
- Lin, Yu-Wen
- Chiang, Chien-Ping
- Wang, Jehng-Kang
- Lin, Chen-Yong
- Johnson, Michael D
Publication details: PloS one 2018
In:
PloS one vol. 13
Availability: No items available.
|
|
34.
|
Tissue distribution and subcellular localizations determine in vivo functional relationship among prostasin, matriptase, HAI-1, and HAI-2 in human skin. [electronic resource] by
- Lee, Shiao-Pieng
- Kao, Chen-Yu
- Chang, Shun-Cheng
- Chiu, Yi-Lin
- Chen, Yen-Ju
- Chen, Ming-Hsing G
- Chang, Chun-Chia
- Lin, Yu-Wen
- Chiang, Chien-Ping
- Wang, Jehng-Kang
- Lin, Chen-Yong
- Johnson, Michael D
Producer: 20180412
In:
PloS one vol. 13
Availability: No items available.
|
|
35.
|
An open-label, phase 1 study evaluating safety, tolerability, and pharmacokinetics of linifanib (ABT-869) in Japanese patients with solid tumors. [electronic resource] by
- Asahina, Hajime
- Tamura, Yosuke
- Nokihara, Hiroshi
- Yamamoto, Noboru
- Seki, Yoshitaka
- Shibata, Takashi
- Goto, Yasushi
- Tanioka, Maki
- Yamada, Yasuhide
- Coates, Andrew
- Chiu, Yi-Lin
- Li, Xiaohui
- Pradhan, Rajendra
- Ansell, Peter J
- McKeegan, Evelyn M
- McKee, Mark D
- Carlson, Dawn M
- Tamura, Tomohide
Producer: 20120803
In:
Cancer chemotherapy and pharmacology vol. 69
Availability: No items available.
|
|
36.
|
Natural Endogenous Human Matriptase and Prostasin Undergo Zymogen Activation via Independent Mechanisms in an Uncoupled Manner. [electronic resource] by
- Su, Hui Chen
- Liang, Yan A
- Lai, Ying-Jung J
- Chiu, Yi-Lin
- Barndt, Robert B
- Shiao, Frank
- Chang, Hsiang-Hua D
- Lu, Dajun D
- Huang, Nanxi
- Tseng, Chun-Che
- Wang, Jehng-Kang
- Lee, Ming-Shyue
- Johnson, Michael D
- Huang, Shih-Ming
- Lin, Chen-Yong
Producer: 20170706
In:
PloS one vol. 11
Availability: No items available.
|
|
37.
|
Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity. [electronic resource] by
- Wilson, Wyndham H
- O'Connor, Owen A
- Czuczman, Myron S
- LaCasce, Ann S
- Gerecitano, John F
- Leonard, John P
- Tulpule, Anil
- Dunleavy, Kieron
- Xiong, Hao
- Chiu, Yi-Lin
- Cui, Yue
- Busman, Todd
- Elmore, Steven W
- Rosenberg, Saul H
- Krivoshik, Andrew P
- Enschede, Sari H
- Humerickhouse, Rod A
Producer: 20110112
In:
The Lancet. Oncology vol. 11
Availability: No items available.
|
|
38.
|
Phase I study of Navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumors. [electronic resource] by
- Gandhi, Leena
- Camidge, D Ross
- Ribeiro de Oliveira, Moacyr
- Bonomi, Philip
- Gandara, David
- Khaira, Divis
- Hann, Christine L
- McKeegan, Evelyn M
- Litvinovich, Elizabeth
- Hemken, Philip M
- Dive, Caroline
- Enschede, Sari H
- Nolan, Cathy
- Chiu, Yi-Lin
- Busman, Todd
- Xiong, Hao
- Krivoshik, Andrew P
- Humerickhouse, Rod
- Shapiro, Geoffrey I
- Rudin, Charles M
Producer: 20110506
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 29
Availability: No items available.
|
|
39.
|
Preclinical discovery of candidate genes to guide pharmacogenetics during phase I development: the example of the novel anticancer agent ABT-751. [electronic resource] by
- Innocenti, Federico
- Ramírez, Jacqueline
- Obel, Jennifer
- Xiong, Julia
- Mirkov, Snezana
- Chiu, Yi-Lin
- Katz, David A
- Carr, Robert A
- Zhang, Wei
- Das, Soma
- Adjei, Araba
- Moyer, Ann M
- Chen, Pei Xian
- Krivoshik, Andrew
- Medina, Diane
- Gordon, Gary B
- Ratain, Mark J
- Sahelijo, Leonardo
- Weinshilboum, Richard M
- Fleming, Gini F
- Bhathena, Anahita
Producer: 20140203
In:
Pharmacogenetics and genomics vol. 23
Availability: No items available.
|